Susan Clement-Davies and Professor Sir Robert Lechler join the Board on 1 January 2022 MiNA Therapeutics Limited ("MiNA" or the "Company"), the pioneer in small activating RNA (RNAa) therapeutics
Speaker Interview With Mr Nagy Habib, Imperial College London For Oligonucleotide Therapeutics And Delivery Released einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Oligonucleotide Therapeutics and Delivery 2021
SMi reports: Speakers confirmed at Oligonucleotide Therapeutics and Delivery Conference, which will convene in London on 22nd and 23rd September. LONDON, LONDON BRIDGE , UNITED KINGDOM, May 11, 2021 /EINPresswire.com/ Oligonucleotidetherapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material via antisense, mRNA, RNAi, saRNA and siRNA. The Oligonucleotide Therapeutics and Delivery conference is here to keep you updated with discussions that will be centered around improving targeted therapy uniting the field’s biggest players to share their opinions. This year’s agenda will encompass key drivers and hot topics of the industry including recent advances in oligonucleotide therapeutics, optimising oligonucleotide development strategies, clinical advances of RNAi therapy and emerging delivery solutions.